Stay updated on TAK-659 in AML Clinical Trial
Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.

Latest updates to the TAK-659 in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA single 'Locations' section lists all study sites (Alabama, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, North Carolina, Ohio, Texas, Wisconsin, Nova Scotia, Ontario) under one heading, replacing the prior separate location entries. The revision label updated to v3.3.3.SummaryDifference1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe Publications note now states that PubMed auto-fills publications and may not be about the study, and the Revision tag has been updated to v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the site-wide notice about government funding delays and NIH operating status; the banner confirming potential delays is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant changes were observed on the page; the study details, eligibility criteria, and locations sections appear unchanged.SummaryDifference0.4%

- Check99 days agoChange DetectedCore content updated with a government operating status notice and a new version tag; a specific disease resource entry was removed.SummaryDifference2%

- Check106 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.0%

Stay in the know with updates to TAK-659 in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.